Cargando…

12: AN EVIDENCE-BASED REVIEW REGARDING OFF-LABEL PRESCRIPTIONS OF POLIDOCANOL

Polidocanol is approved for its competence in treatment of varicose veins and spider veins; however, unfortunately, many of its off-label uses are still underappreciated. Lack of an appropriate comprehensive review for off-label uses of this medication troubles physicians about making evidence-based...

Descripción completa

Detalles Bibliográficos
Autor principal: Ebrahimi, Seyyed Reza Sadat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759435/
http://dx.doi.org/10.1136/bmjopen-2016-015415.12
_version_ 1783291198104928256
author Ebrahimi, Seyyed Reza Sadat
author_facet Ebrahimi, Seyyed Reza Sadat
author_sort Ebrahimi, Seyyed Reza Sadat
collection PubMed
description Polidocanol is approved for its competence in treatment of varicose veins and spider veins; however, unfortunately, many of its off-label uses are still underappreciated. Lack of an appropriate comprehensive review for off-label uses of this medication troubles physicians about making evidence-based decisions on prescribing it for its various outstanding off-label uses. This article attempts to provide physicians with the latest information concerning successful and unsuccessful use of polidocanol as an alternative treatment for esophageal and gastric varices, tendinopathy and epicondylitis, vascular malformations, varicocele, hydrocele and spermatocele, aneurysmal bone cysts, Itching, management of gastrointestinal bleeding, simple renal cysts, reducing the incidence and severity of radio-induced dermatitis, and hemorrhoids. Polidocanol eligibility as an alternative prescription, in comparison to other standard medications in each condition, is also discussed meticulously afterwards in this paper.
format Online
Article
Text
id pubmed-5759435
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57594352018-02-12 12: AN EVIDENCE-BASED REVIEW REGARDING OFF-LABEL PRESCRIPTIONS OF POLIDOCANOL Ebrahimi, Seyyed Reza Sadat BMJ Open Abstracts from the 5th International Society for Evidence-Based Healthcare Congress, Kish Island, Ira Polidocanol is approved for its competence in treatment of varicose veins and spider veins; however, unfortunately, many of its off-label uses are still underappreciated. Lack of an appropriate comprehensive review for off-label uses of this medication troubles physicians about making evidence-based decisions on prescribing it for its various outstanding off-label uses. This article attempts to provide physicians with the latest information concerning successful and unsuccessful use of polidocanol as an alternative treatment for esophageal and gastric varices, tendinopathy and epicondylitis, vascular malformations, varicocele, hydrocele and spermatocele, aneurysmal bone cysts, Itching, management of gastrointestinal bleeding, simple renal cysts, reducing the incidence and severity of radio-induced dermatitis, and hemorrhoids. Polidocanol eligibility as an alternative prescription, in comparison to other standard medications in each condition, is also discussed meticulously afterwards in this paper. BMJ Publishing Group 2017-02-08 /pmc/articles/PMC5759435/ http://dx.doi.org/10.1136/bmjopen-2016-015415.12 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Abstracts from the 5th International Society for Evidence-Based Healthcare Congress, Kish Island, Ira
Ebrahimi, Seyyed Reza Sadat
12: AN EVIDENCE-BASED REVIEW REGARDING OFF-LABEL PRESCRIPTIONS OF POLIDOCANOL
title 12: AN EVIDENCE-BASED REVIEW REGARDING OFF-LABEL PRESCRIPTIONS OF POLIDOCANOL
title_full 12: AN EVIDENCE-BASED REVIEW REGARDING OFF-LABEL PRESCRIPTIONS OF POLIDOCANOL
title_fullStr 12: AN EVIDENCE-BASED REVIEW REGARDING OFF-LABEL PRESCRIPTIONS OF POLIDOCANOL
title_full_unstemmed 12: AN EVIDENCE-BASED REVIEW REGARDING OFF-LABEL PRESCRIPTIONS OF POLIDOCANOL
title_short 12: AN EVIDENCE-BASED REVIEW REGARDING OFF-LABEL PRESCRIPTIONS OF POLIDOCANOL
title_sort 12: an evidence-based review regarding off-label prescriptions of polidocanol
topic Abstracts from the 5th International Society for Evidence-Based Healthcare Congress, Kish Island, Ira
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759435/
http://dx.doi.org/10.1136/bmjopen-2016-015415.12
work_keys_str_mv AT ebrahimiseyyedrezasadat 12anevidencebasedreviewregardingofflabelprescriptionsofpolidocanol